Recent research has focused on the tumour mutation burden, interferon-γ gene signature and tumour immune status on the basis of PD-L1 expression and CD8+TILs as representative predictive candidates of immunotherapy.14,37,45 However, invasive tumour tissue sampling is warranted to analyse the protein expression and extract the DNA and RNA derived from tumour tissues. This evidence concerns the gene CD8A and neoplasm.